PDS Biotechnology Corpora... (PDSB)
NASDAQ: PDSB
· Real-Time Price · USD
1.20
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
1.22
1.66%
After-hours: Aug 15, 2025, 07:12 PM EDT
PDS Biotechnology Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -35.5M | -37.61M | -40.56M | -40.68M | -43.88M | -42.94M | -51.18M | -47.76M | -42.04M | -40.85M | -28.04M | -27.57M | -22.34M | -16.92M | -14.63M | -11.57M | -13.91M |
Depreciation & Amortization | 50.84K | 50.12K | 39.73K | 29.33K | 18.94K | 17.36K | 24.2K | 117.14K | 112.49K | 109.42K | 98.8K | 2.4K | 3.58K | 5.36K | 8.31K | 10.94K | 13.57K |
Stock-Based Compensation | 6.47M | 6.85M | 6.56M | 6.86M | 7.17M | 7.62M | 7.63M | 6.9M | 6.15M | 5.2M | 5.5M | 5.85M | 4.95M | 4.11M | 2.57M | 996.18K | 610.87K |
Other Working Capital | -3.65M | -453.77K | 953.78K | -1.53M | 427.99K | -5.96M | 1.12M | 887.76K | -1.57M | 4.57M | -1.08M | 56.9K | 304.96K | 181.64K | -748.28K | 287.78K | 884.39K |
Other Non-Cash Items | 1.64M | 1.43M | 1.58M | 1.83M | 319.96K | 233.91K | 4.03M | 3.65M | 4.67M | 4.53M | 351.08K | 240.94K | 241.03K | 241.03K | 297.11K | 302K | 226.09K |
Deferred Income Tax | n/a | n/a | 232.59K | 232.59K | 1.64M | 1.64M | 1.41M | 1.31M | -97.67K | -97.67K | -10.7M | -10.6M | -10.6M | -10.6M | n/a | n/a | n/a |
Change in Working Capital | -6.79M | -5.75M | -3.11M | -2.7M | 4.36M | -198.31K | 4.45M | 3.43M | -2.24M | 4.48M | -492.64K | -440.47K | 2.1M | 75.85K | -862.03K | 1.52M | -784K |
Operating Cash Flow | -34.12M | -35.03M | -35.25M | -34.43M | -30.39M | -33.64M | -32.71M | -31.43M | -32.53M | -25.71M | -22.68M | -21.92M | -15.05M | -12.49M | -12.61M | -8.74M | -13.79M |
Capital Expenditures | -29K | -29K | -29K | -29K | n/a | -4 | 3.00 | -1 | -7 | -4 | -2 | 7.00 | 9.00 | 10.00 | 5.00 | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -29M | -29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -29M | -29M | -29K | -29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | -6.31M | -3.18M | -54.54K | -53.31K | -52.11K | -59.3K | -46.13K | 24.97M | 24.98M | 25M | 25M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.4M | 773.75K | 930.15K | 831.65K | 840.5K | 4.9M | 4.45M | 4M | 3.99M | -598.79K | -449.33K | n/a | 220.6K | 220.6K | 29.8B | 29.82B | 29.81B |
Financial Cash Flow | 7.5M | 20.19M | 30.78M | 31.57M | 31.82M | 16.38M | 15.32M | 39.07M | 38.85M | 34.29M | 24.58M | 153.44K | 48.9M | 48.89M | 29.85B | 29.86B | 29.81B |
Net Cash Flow | -26.66M | -14.87M | -4.5M | -2.89M | 1.44M | -17.26M | -17.39M | 7.64M | 6.32M | 8.58M | 1.9M | -21.76M | 33.84M | 36.4M | 36.28M | 57.81M | 4M |
Free Cash Flow | -34.15M | -35.06M | -35.28M | -34.46M | -30.39M | -33.64M | -32.71M | -31.43M | -32.53M | -25.71M | -22.68M | -21.92M | -15.05M | -12.49M | -12.61M | -8.74M | -13.79M |